GlucoSet are developing a minimally invasive, real-time continuous glucose monitoring (CGM) system designed for intensive care units (ICUs). Their intravascular sensor, inserted through existing arterial catheters, provides accurate and continuous blood glucose measurements, aiming to improve patient outcomes by reducing complications associated with abnormal glucose levels, such as sepsis and renal failure.